BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28349351)

  • 1. Advanced MRI Techniques in the Monitoring of Treatment of Gliomas.
    Hyare H; Thust S; Rees J
    Curr Treat Options Neurol; 2017 Mar; 19(3):11. PubMed ID: 28349351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques.
    Henriksen OM; Del Mar Álvarez-Torres M; Figueiredo P; Hangel G; Keil VC; Nechifor RE; Riemer F; Schmainda KM; Warnert EAH; Wiegers EC; Booth TC
    Front Oncol; 2022; 12():810263. PubMed ID: 35359414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
    Kim JY; Park JE; Jo Y; Shim WH; Nam SJ; Kim JH; Yoo RE; Choi SH; Kim HS
    Neuro Oncol; 2019 Feb; 21(3):404-414. PubMed ID: 30107606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.
    Tensaouti F; Khalifa J; Lusque A; Plas B; Lotterie JA; Berry I; Laprie A; Cohen-Jonathan Moyal E; Lubrano V
    Neuroradiology; 2017 Oct; 59(10):1013-1020. PubMed ID: 28842741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
    Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
    BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced magnetic resonance imaging in glioblastoma: a review.
    Shukla G; Alexander GS; Bakas S; Nikam R; Talekar K; Palmer JD; Shi W
    Chin Clin Oncol; 2017 Aug; 6(4):40. PubMed ID: 28841802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.
    Mert A; Kiesel B; Wöhrer A; Martínez-Moreno M; Minchev G; Furtner J; Knosp E; Wolfsberger S; Widhalm G
    Neurosurg Focus; 2015 Jan; 38(1):E4. PubMed ID: 25552284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.
    Huang RY; Neagu MR; Reardon DA; Wen PY
    Front Neurol; 2015; 6():33. PubMed ID: 25755649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas.
    Zikou A; Sioka C; Alexiou GA; Fotopoulos A; Voulgaris S; Argyropoulou MI
    Contrast Media Mol Imaging; 2018; 2018():6828396. PubMed ID: 30627060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
    Wen PY; van den Bent M; Youssef G; Cloughesy TF; Ellingson BM; Weller M; Galanis E; Barboriak DP; de Groot J; Gilbert MR; Huang R; Lassman AB; Mehta M; Molinaro AM; Preusser M; Rahman R; Shankar LK; Stupp R; Villanueva-Meyer JE; Wick W; Macdonald DR; Reardon DA; Vogelbaum MA; Chang SM
    J Clin Oncol; 2023 Nov; 41(33):5187-5199. PubMed ID: 37774317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
    Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
    Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudoprogression and pseudoresponse in the treatment of gliomas.
    Brandsma D; van den Bent MJ
    Curr Opin Neurol; 2009 Dec; 22(6):633-8. PubMed ID: 19770760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.
    Shiroishi MS; Boxerman JL; Pope WB
    Neuro Oncol; 2016 Apr; 18(4):467-78. PubMed ID: 26364321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How treatment monitoring is influencing treatment decisions in glioblastomas.
    Neagu MR; Huang RY; Reardon DA; Wen PY
    Curr Treat Options Neurol; 2015 Apr; 17(4):343. PubMed ID: 25749847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation.
    Linhares P; Carvalho B; Figueiredo R; Reis RM; Vaz R
    J Oncol; 2013; 2013():690585. PubMed ID: 24000284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 - Radiological features and metric markers.
    Le Fèvre C; Constans JM; Chambrelant I; Antoni D; Bund C; Leroy-Freschini B; Schott R; Cebula H; Noël G
    Crit Rev Oncol Hematol; 2021 Mar; 159():103230. PubMed ID: 33515701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.
    Kickingereder P; Isensee F; Tursunova I; Petersen J; Neuberger U; Bonekamp D; Brugnara G; Schell M; Kessler T; Foltyn M; Harting I; Sahm F; Prager M; Nowosielski M; Wick A; Nolden M; Radbruch A; Debus J; Schlemmer HP; Heiland S; Platten M; von Deimling A; van den Bent MJ; Gorlia T; Wick W; Bendszus M; Maier-Hein KH
    Lancet Oncol; 2019 May; 20(5):728-740. PubMed ID: 30952559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New opportunities, MRI biomarkers in the evaluation of head and neck cancer].
    Gődény M; Léránt G
    Magy Onkol; 2014 Dec; 58(4):269-80. PubMed ID: 25517445
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.